HIV pre-exposure prophylaxis re-initiation among men who have sex with men: a multi-center cohort study in China.

IF 1.8 4区 医学 Q3 INFECTIOUS DISEASES
Sexual health Pub Date : 2025-03-01 DOI:10.1071/SH24200
Yifan Dai, Zhuoheng Yin, Chunyan Li, Chengxin Fan, Heping Zhao, Haojie Huang, Quanmin Li, Songjie Wu, Aniruddha Hazra, Jonathan Lio, Ke Liang, Linghua Li, Renslow Sherer, Joseph D Tucker, Cheng Wang, Weiming Tang
{"title":"HIV pre-exposure prophylaxis re-initiation among men who have sex with men: a multi-center cohort study in China.","authors":"Yifan Dai, Zhuoheng Yin, Chunyan Li, Chengxin Fan, Heping Zhao, Haojie Huang, Quanmin Li, Songjie Wu, Aniruddha Hazra, Jonathan Lio, Ke Liang, Linghua Li, Renslow Sherer, Joseph D Tucker, Cheng Wang, Weiming Tang","doi":"10.1071/SH24200","DOIUrl":null,"url":null,"abstract":"<p><p>Background Data on persistent use of HIV pre-exposure prophylaxis (PrEP) is limited among Chinese men who have sex with men (MSM). This study aimed to explore factors associated with the re-initiation of PrEP among Chinese MSM from a longitudinal PrEP demonstration trial. Methods A multi-center cohort study was conducted in Guangzhou and Wuhan, China (September 2021-2024), providing 1134 MSM participants with a 12-month dosage of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) as oral PrEP. Following the trial, a subgroup of participants were invited to complete a 3-month post-trial follow-up survey. These participants were categorized on the basis of self-reported PrEP use patterns into (1) continued PrEP use, (2) discontinued without re-initiation, and (3) re-initiated after discontinuation. Log-binomial regression models were used to assess factors associated with PrEP re-initiation. Results Out of 408 participants who completed the 3-month post-trial follow-up survey, 70.1% (n =286/408) reported discontinuing PrEP, and 50.7% (n =145/286) of those who discontinued subsequently re-initiated PrEP. Participants who had concurrent sexual partnerships (adjusted risk ratio [aRR]=1.47, 95% CI: 1.11-1.96), used drugs during sex (aRR=1.34, 95% CI: 1.09-1.65), or lived alone (aRR=1.29, 95% CI: 1.03-1.61) were more likely to re-initiate PrEP. The Likert scale analysis indicated that perceived partner influence, specifically the expectation of condomless sex, played a significant role in re-initiation decisions (P =0.03). Conclusion Individuals engaging in higher-risk behaviors are more likely to re-initiate PrEP, highlighting the dynamic nature of risk perception. Future interventions should focus on promoting both re-initiation and consistent condom use, emphasizing partner-related dynamics and substance use as key factors in PrEP decisions among MSM.</p>","PeriodicalId":22165,"journal":{"name":"Sexual health","volume":"22 ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1071/SH24200","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background Data on persistent use of HIV pre-exposure prophylaxis (PrEP) is limited among Chinese men who have sex with men (MSM). This study aimed to explore factors associated with the re-initiation of PrEP among Chinese MSM from a longitudinal PrEP demonstration trial. Methods A multi-center cohort study was conducted in Guangzhou and Wuhan, China (September 2021-2024), providing 1134 MSM participants with a 12-month dosage of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) as oral PrEP. Following the trial, a subgroup of participants were invited to complete a 3-month post-trial follow-up survey. These participants were categorized on the basis of self-reported PrEP use patterns into (1) continued PrEP use, (2) discontinued without re-initiation, and (3) re-initiated after discontinuation. Log-binomial regression models were used to assess factors associated with PrEP re-initiation. Results Out of 408 participants who completed the 3-month post-trial follow-up survey, 70.1% (n =286/408) reported discontinuing PrEP, and 50.7% (n =145/286) of those who discontinued subsequently re-initiated PrEP. Participants who had concurrent sexual partnerships (adjusted risk ratio [aRR]=1.47, 95% CI: 1.11-1.96), used drugs during sex (aRR=1.34, 95% CI: 1.09-1.65), or lived alone (aRR=1.29, 95% CI: 1.03-1.61) were more likely to re-initiate PrEP. The Likert scale analysis indicated that perceived partner influence, specifically the expectation of condomless sex, played a significant role in re-initiation decisions (P =0.03). Conclusion Individuals engaging in higher-risk behaviors are more likely to re-initiate PrEP, highlighting the dynamic nature of risk perception. Future interventions should focus on promoting both re-initiation and consistent condom use, emphasizing partner-related dynamics and substance use as key factors in PrEP decisions among MSM.

中国男男性行为者HIV暴露前预防再启动:一项多中心队列研究
背景:中国男男性行为者(MSM)持续使用HIV暴露前预防(PrEP)的数据有限。本研究旨在通过一项纵向PrEP示范试验,探讨中国MSM人群重新开始PrEP的相关因素。方法在中国广州和武汉(2021年9月-2024年9月)进行了一项多中心队列研究,为1134名MSM参与者提供了12个月剂量的富马酸替诺福韦二氧吡酯和恩曲他滨(TDF/FTC)作为口服PrEP。试验结束后,邀请一组参与者完成3个月的试验后随访调查。这些参与者根据自我报告的PrEP使用模式分为(1)继续使用PrEP,(2)停止使用PrEP而未重新开始,(3)停止后重新开始使用PrEP。采用对数-二项回归模型评估与PrEP再启动相关的因素。在408名完成3个月后随访调查的参与者中,70.1% (n =286/408)报告停止PrEP, 50.7% (n =145/286)报告停止PrEP后重新开始PrEP。有并发性伴侣的参与者(调整风险比[aRR]=1.47, 95% CI: 1.11-1.96),在性行为中使用药物(aRR=1.34, 95% CI: 1.09-1.65),或独居(aRR=1.29, 95% CI:1.03-1.61)更有可能再次开始PrEP。李克特量表分析表明,感知到的伴侣影响,特别是对无安全套性行为的期望,在再次开始的决定中起着重要作用(P =0.03)。结论高危行为的个体更有可能重新启动PrEP,突出了风险感知的动态性。未来的干预措施应侧重于促进重新开始和持续使用避孕套,强调与伴侣有关的动态和物质使用是男男性行为者决定预防措施的关键因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sexual health
Sexual health 医学-传染病学
CiteScore
2.30
自引率
12.50%
发文量
121
审稿时长
6-12 weeks
期刊介绍: Sexual Health publishes original and significant contributions to the fields of sexual health including HIV/AIDS, Sexually transmissible infections, issues of sexuality and relevant areas of reproductive health. This journal is directed towards those working in sexual health as clinicians, public health practitioners, researchers in behavioural, clinical, laboratory, public health or social, sciences. The journal publishes peer reviewed original research, editorials, review articles, topical debates, case reports and critical correspondence. Officially sponsored by: The Australasian Chapter of Sexual Health Medicine of RACP Sexual Health Society of Queensland Sexual Health is the official journal of the International Union against Sexually Transmitted Infections (IUSTI), Asia-Pacific, and the Asia-Oceania Federation of Sexology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信